Characterizing κ(3) opioid receptors with a selective monoclonal antibody Journal Article


Authors: Brooks, A. I.; Standifer, K. M.; Rossi, G. C.; Mathis, J. P.; Pasternak, G. W.
Article Title: Characterizing κ(3) opioid receptors with a selective monoclonal antibody
Abstract: To help characterize κ3 receptors and establish their relationship to traditional μ and δ receptors, we have generated a κ3-selective monoclonal antibody. Monoclonal antibodies were raised against BE(2)-C cells, a human neuroblastoma cell line containing μ, κ3, and δ opioid receptors. Of the 5,000 hybridoma cell lines screened, approximately 2,000 hybridomas tested positive against BE(2)-C membranes by ELISA, but only 98 of these were negative against a different neuroblastoma cell line lacking opioid receptors. Supernatants from one hybridoma, 8D8, inhibited up to 90% of 3H- NalBzoH (κ3) binding without affecting 3H-DAMGO (μ) or 3H-naltrindole (δ) binding in BE(2)-C membranes. The selectivity of the antibody was further demonstrated by its blockade of the inhibition of cAMP accumulation in BE(2)-C cells by the κ3 agonist NalBzoH but not the μ agonist morphine. Monoclonal antibody 8D8 (mAb8D8) also recognizes κ3 receptors from mouse, rat, and calf brain. Administered intracerebroventricularly, mAb8D8 blocked κ3 but not morphine (μ) analgesia in vivo. On Western blots, mAb8D8 recognized a protein with a molecular mass of approximately 70 kilodaltons in BE(2)-C. These studies demonstrate the selectivity of mAb8D8 for κ3 receptors and provide additional support for the existence of this unique opioid receptor subtype.
Keywords: controlled study; nonhuman; brain tumor; brain neoplasms; mouse; animal; metabolism; animals; mice; animal tissue; opiate; drug effect; tumor cells, cultured; enzyme linked immunosorbent assay; monoclonal antibody; mice, inbred strains; blotting, western; immunology; antibodies, monoclonal; narcotic analgesic agent; diagnostic agent; cell culture; neuroblastoma; rat; western blotting; cyclic amp; rats; receptor affinity; mouse strain; enzyme-linked immunosorbent assay; analgesics, opioid; pain measurement; analgesia; pain assessment; receptor binding; binding competition; opioid peptides; binding, competitive; antinociception; kappa opiate receptor; opiate peptide; mu opioid receptor; male; priority journal; article; receptors, opioid, kappa; delta opioid receptor; camp accumulation
Journal Title: Synapse
Volume: 22
Issue: 3
ISSN: 0887-4476
Publisher: John Wiley & Sons  
Date Published: 1996-03-01
Start Page: 247
End Page: 252
Language: English
DOI: 10.1002/(sici)1098-2396(199603)22:3<247::aid-syn7>3.0.co;2-c
PUBMED: 9132993
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Grace Rossi
    61 Rossi
  2. Gavril W Pasternak
    414 Pasternak
  3. John P Mathis
    21 Mathis
  4. Andrew I. Brooks
    11 Brooks